Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2010
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized studyDaniel Keizman, Marianna Zahurak, Victoria Sinibaldi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2022
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancerSnir Dekalo, Jonathan Kuten, Jeffrey Campbell, et al.
The Prostate|March 25, 2011
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivationDaniel Keizman, Peng Huang, Emmanuel S Antonarakis, et al.
Cancer|November 6, 2009
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugateDaniel Keizman, Natalie Maimon, Maya Ish-Shalom, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
The Prostate|July 13, 2011
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J Zabransky, Heath A Smith, Christopher J Thoburn, et al.
Clinical Genitourinary Cancer|July 29, 2014
Activity of cabazitaxel after docetaxel and abiraterone acetate therapy in patients with castration-resistant prostate cancerAvishay Sella, Tal Sella, Avivit Peer, et al.
Prostate Cancer and Prostatic Diseases|April 1, 2021
Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissectionSnir Dekalo, Jonathan Kuten, Ishai Mintz, et al.
Cancer|June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
Pageof 5